CNS Forecast



Bearish   ↔   Bullish



80% Confidence




Bullish Case: CNS mean-reverts persistently: six months of my 'sideways/mean-revert' calls held while the crash tail never triggered. At $72.53 (+8.3% YoY), the return surface concentrates mass near small positive returns, Helium's density peaks near $70-75, ATM IV is moderate (~30-35%), and dividends/buybacks with zero debt anchor AUM-driven cash flow. Deep-put IVs (100-149%) are stale tail-hedging noise, not information—near-zero volume confirms illiquid quotes.




Bearish Case: CNS is -24.5% over five years and -25.6% over two, with P/B 16.1, negative multi-year EPS/EBITDA growth, and backwardated options. -6.4% over sixty days shows downtrend pressure. Deep OTM puts at 100-149% IV signal genuine priced tail risk, and SPY's surface shows rising downside vol into 2027—a rate/credit shock would compress this valuation quickly.




Potential Outcomes:
  1. Mean-reversion $69-76 (45%) — return-surface mass + Helium/market densities both peak near $70-75; falsified by close <$68.
  2. Rate/credit pullback to $63-68 (25%) — SPY downside IV rising into 2027; falsified if CNS IV falls.
  3. Yield re-rating to $78-85 (18%) — dividend/FCF confirmation; falsified on weak guidance.
  4. Macro crash <$63 (12%) — deep-put tail; falsified if deep-put IV mean-reverts absent stress.



October 31, 2026















See risk, trade-offs, and measured results before you decide.